World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
27513
World Ranking
15034
National Ranking
7600

Marshall R. Posner publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Marshall R. Posner sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 412 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Marshall R. Posner D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Marshall R. Posner sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Marshall R. Posner is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on medical and oncological studies with a significant emphasis on head and neck cancers, human papillomavirus (HPV) related malignancies, and cancer diagnostics.

The scientist has contributed extensively to the field of Medicine, with a total of 196 publications. Key subfields of study include:

  • Otorhinolaryngology
  • Oncology
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Epidemiology

Posner's main research topics cover various aspects related to cancer, including:

  • Head and Neck Cancer Studies
  • Head and Neck Surgical Oncology
  • Cervical Cancer and HPV Research
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Cancer Diagnosis and Treatment

Their work has been published across several frequent venues, illustrating their active engagement within the oncology and clinical research communities:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Oral Oncology
  • Regular and Young Investigator Award Abstracts
  • Clinical Cancer Research

Among the recent scientific papers authored or coauthored by Posner are:

  • Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma, 2022, Clinical Cancer Research
  • Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis, 2021, The Lancet Oncology
  • Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer, 2023, JAMA Otolaryngology-Head & Neck Surgery
  • Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, 2023, Clinical Cancer Research
  • De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial, 2021, The Oncologist

Frequent coauthors collaborating with Posner include:

  • Eric M. Genden
  • Richard L. Bakst
  • Krzysztof Misiukiewicz
  • Scott A. Roof
  • Brett A. Miles

Marshall R. Posner's research contributions span clinical and translational studies, particularly in the application of liquid biopsies and molecular diagnostics for HPV-related cancers, as well as treatments involving chemotherapy, radiotherapy, and surgical interventions.

Best Publications

  • Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

    Marshall R. Posner;Diane M. Hershock;Cesar R. Blajman;Elizabeth Mickiewicz

  • Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.

    Timothy W. Baba;Vladimir Liska;Regina Hofmann-Lehmann;Josef Vlasak

  • Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.

    Robert Haddad;Robert Haddad;Anne O'Neill;Guilherme Rabinowits;Roy Tishler

  • American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer

    David G. Pfister;Scott A. Laurie;Gregory S. Weinstein;William M. Mendenhall

  • Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.

    A. Razzaque Ahmed;Zachary Spigelman;Lisa A. Cavacini;Marshall R. Posner

  • Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

    M. R. Posner;J. H. Lorch;O. Goloubeva;M. Tan

  • Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial.

    Jochen H Lorch;Olga Goloubeva;Robert I Haddad;Kevin Cullen

  • Head and Neck Cancers

    David G. Pfister;Kie Kian Ang;David M. Brizel;Barbara A. Burtness

  • Human Papillomavirus Type 16 and Squamous Cell Carcinoma of the Head and Neck

    Elin Ringström;Edward Peters;Masayuki Hasegawa;Marshall Posner

  • An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection.

    M R Posner;T Hideshima;T Cannon;M Mukherjee

  • Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.

    Lei Chen;Young Do Kwon;Tongqing Zhou;Xueling Wu

  • Symbiotic Nitrogen Fixation in the Fungus Gardens of Leaf-Cutter Ants

    Adrián A. Pinto-Tomás;Mark A. Anderson;Garret Suen;Garret Suen;David M. Stevenson

  • Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

    Pierre Blanchard;Jean Bourhis;Benjamin Lacas;Marshall R. Posner

  • Lack of Association of Alcohol and Tobacco with HPV16-Associated Head and Neck Cancer

    Katie M. Applebaum;C. Sloane Furniss;Ariana Zeka;Marshall R. Posner

  • Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients

    Kathleen Settle;Marshall R. Posner;Lisa M. Schumaker;Ming Tan

  • Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

    A. I. Dreyfuss;J. R. Clark;C. M. Norris;Renee M Rossi

  • An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.

    T J Ervin;J R Clark;R R Weichselbaum;B G Fallon

  • Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival.

    Carmen J Marsit;Mei Liu;Heather H Nelson;Marshall Posner

  • Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study.

    Robert Haddad;A. Dimitrios Colevas;Jeffrey F. Krane;Dennis Cooper

  • Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy

    Hale B. Caglar;Roy B. Tishler;Megan Othus;Elaine Burke

Frequent Co-Authors

Robert I. Haddad
Robert I. Haddad Harvard University
Lisa A. Cavacini
Lisa A. Cavacini University of Massachusetts Chan Medical School
Karl T. Kelsey
Karl T. Kelsey Brown University
Ralph R. Weichselbaum
Ralph R. Weichselbaum University of Chicago
Peter M. Som
Peter M. Som Icahn School of Medicine at Mount Sinai
Yi Li
Yi Li University of Michigan–Ann Arbor
Karen S. Anderson
Karen S. Anderson Yale University
Ruth M. Ruprecht
Ruth M. Ruprecht Texas Biomedical Research Institute
David Zhang
David Zhang Chinese University of Hong Kong, Shenzhen
Hermann Katinger
Hermann Katinger BOKU University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible study options, online degrees offer a variety of entry points and career advancements. Nursing remains a popular pathway, with bridge programs like the adn to fnp helping registered nurses move toward advanced practice roles. Similarly, rn to bsn online no clinicals accredited programs provide an accredited route to further nursing credentials with minimal on-site requirements.

For those who are interested in health beyond clinical practice, you might consider a bachelor's in nutrition online. This degree can open doors to wellness, dietary consulting, and research positions.

Aspiring healthcare leaders may benefit from the flexibility and recognition of cahme accredited online mha programs list, which are designed to prepare graduates for management roles in healthcare organizations.

These related online degrees offer varied pathways to make a difference in healthcare, each meeting different needs and professional goals.

Best Scientists Citing Marshall R. Posner

Trending Scientists